Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Radiographics ; 39(3): 668-689, 2019.
Article in English | MEDLINE | ID: mdl-30951438

ABSTRACT

Gastric cancer is a leading cause of cancer-related deaths worldwide and is associated with an overall 5-year survival rate of less than 20%. The most common histologic subtype of gastric cancer is adenocarcinoma. Imaging techniques for evaluating gastric adenocarcinoma include endoscopic US, fluoroscopic upper gastrointestinal imaging, CT, PET/CT, and MRI. Hydrodynamic multiphasic contrast material-enhanced CT is the imaging modality of choice for preoperative clinical staging of regional, nodal, and metastatic involvement. Radiologic manifestations of gastric adenocarcinoma at double-contrast upper gastrointestinal imaging and CT include polyps, ulceration, indistensibility, wall thickening, and abnormal enhancement. There are multiple pathways of disease spread. These pathways include lymphatic dissemination; subperitoneal dissemination along the perigastric ligaments, mesentery, or omentum; direct invasion into adjacent organs; transperitoneal seeding; and hematogenous dissemination. The spread of disease is affected by the location of the tumor in the stomach, and the ligamentous and lymphatic anatomy. Key imaging features that affect clinical staging with use of the TNM classification system for gastric adenocarcinoma, as described in the eighth edition of the AJCC Cancer Staging Manual, are briefly discussed. Accurate radiologic assessment of gastric adenocarcinoma requires identification of perigastric ligament infiltration, regional and metastatic nodal disease, and direct and metastatic organ involvement, all of which directly affect tumor staging, treatment, and prognosis. ©RSNA, 2019.


Subject(s)
Adenocarcinoma/diagnostic imaging , Ligaments/diagnostic imaging , Lymphatic Metastasis/diagnostic imaging , Stomach Neoplasms/diagnostic imaging , Adenocarcinoma/pathology , Contrast Media , Endosonography , Fluoroscopy , Gastric Outlet Obstruction/diagnostic imaging , Gastroscopy , Humans , Ligaments/pathology , Lymphatic Metastasis/pathology , Multimodal Imaging/methods , Neoplasm Metastasis , Neoplasm Staging , Polyps/diagnostic imaging , Stomach Neoplasms/pathology , Tomography, X-Ray Computed
2.
Curr Radiol Rep ; 7(9): 25, 2019.
Article in English | MEDLINE | ID: mdl-32226652

ABSTRACT

PURPOSE OF REVIEW: Emerging infectious diseases have seen a record increase in prevalence, and understanding their management is critical in an increasingly global community. In this paper, we review current literature detailing the role of radiology in the diagnosis and treatment of the Ebola (EVD), Zika (ZVD), Chikungunya (CHIKF), H1N1, Middle East Respiratory (MERS), and Severe Acute Respiratory Syndrome (SARS) viruses. RECENT FINDINGS: Complex protocols are required to safely use portable imaging in EVD to prevent nosocomial spread of disease. In ZVD, antenatal ultrasound can detect fetal abnormalities early, allowing implementation of care and support to affected families. Imaging is useful in assessing the extent of involvement of chronic CHIKF and monitoring treatment effect. Chest radiography and CT play a more direct role in the diagnosis and monitoring of the viral infections with primarily respiratory manifestations (H1N1, MERS, and SARS). SUMMARY: Radiology plays a variable role in emerging infectious diseases, requiring an understanding of disease transmission and safe imaging practices, as well as imaging features that affect clinical management.

3.
Exp Hematol ; 30(7): 738-44, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12135671

ABSTRACT

OBJECTIVE: A favorable incidence and severity of graft-vs-host disease is observed in patients transplanted with banked, unrelated, HLA-mismatched umbilical cord blood (UCB) grafts, while the incidence of malignant relapse remains low. CTLA-4 mediates negative T-cell signaling and may contribute to the development of allogeneic tolerance. In this study, we compared protein and mRNA expression of CTLA-4 in stimulated UCB and adult peripheral blood T cells. MATERIALS AND METHODS: T cells were isolated from UCB and adult peripheral blood and stimulated with anti-CD3 and anti-CD28 monoclonal antibodies. Cells were immunostained and analyzed by flow cytometry for both surface and intracellular expression of CTLA-4 in the presence and absence of cyclosporin A, and kinetics of CTLA-4 expression compared. CTLA-4 mRNA expression was measured using quantitative real-time polymerase chain reaction. NFAT1 protein levels were measured by Western blot analysis. RESULTS: These studies demonstrate reduced surface and intracellular expression of CTLA-4 in stimulated UCB T cells compared to adult controls. Furthermore, reduced CTLA-4 protein expression in UCB T cells was noted to be in part transcriptionally regulated, as CTLA-4 mRNA levels also were significantly lower. Reduced CLTA-4 expression by UCB T cells followed the kinetics of delayed and reduced expression of the transcription factor NFAT1 by UCB T lymphocytes during primary stimulation. Moreover, cyclosporin A, which is known to modulate NFAT activation, reduced CTLA-4 protein expression in adult and UCB T cells. CONCLUSION: Reduced expression of the key regulatory proteins CTLA-4 and NFAT-1 may contribute to favorable UCB T lymphocyte allogeneic responses.


Subject(s)
Antigens, Differentiation/biosynthesis , Fetal Blood/cytology , Immunoconjugates , Nuclear Proteins , RNA, Messenger/biosynthesis , T-Lymphocytes/metabolism , Abatacept , Adult , Aging/immunology , Antigens, CD , Antigens, Differentiation/genetics , CTLA-4 Antigen , Cell Division/drug effects , Cyclosporine/pharmacology , DNA-Binding Proteins/metabolism , Flow Cytometry , Gene Expression Regulation/drug effects , Graft vs Host Disease/immunology , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Immune Tolerance , Immunosuppressive Agents/pharmacology , Infant, Newborn , Lymphocyte Activation , NFATC Transcription Factors , Polymerase Chain Reaction , RNA, Messenger/genetics , T-Lymphocytes/drug effects , Transcription Factors/metabolism , Transcription, Genetic/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...